Back to Exenatide research
exenatide glp 1 agonist other 2013-06 ClinicalTrials

Terminated Study Explored KATP Channel Impact on GLP-1 Microvascular Function

Incretin and KATP Channels

Background

Glucagon-like peptide-1 (GLP-1) and its analogues like Exenatide and Liraglutide are crucial incretin hormones widely used in Type 2 diabetes management, known for their metabolic and cardiovascular benefits. KATP channels (ATP-sensitive potassium channels) play a vital role in insulin secretion and vascular tone, influencing processes like insulin release and vascular smooth muscle contraction. This study aimed to examine the involvement of KATP channels in the microvascular actions of GLP-1 and its analogues.

Study Design

Population
The study aimed to examine the involvement of KATP channels in the microvascular actions of GLP-1 and its analogues in Type 2 diabetes.
Intervention
GLP-1 and its analogues, Exenatide and Liraglutide, were explored for their impact on microvascular function.
Outcome
The primary outcome was to examine the involvement of KATP channels in the microvascular actions of GLP-1 and its analogues.

exenatide insulin liraglutide glp 1 agonist katp channels dose mentioned
Source: clinicaltrials:NCT01934816 · Ingested 2026-04-29 · Digest: gemini-2.5-flash